Literature DB >> 19694995

Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets.

Alice K Fuller1, Kristin M Uglik, William J Savage, Paul M Ness, Karen E King.   

Abstract

BACKGROUND: Transfusion-associated bacterial sepsis is a significant risk of morbidity and mortality related to platelet (PLT) transfusions. Previously the rate of septic PLT transfusion reactions (SPTRs) to single-donor PLTs (SDPs) in our hospital was determined to be 1 in 15,098 (6.6 per 100,000; 95% confidence interval [CI], 0.17-36.9 per 100,000) transfusions. The goal of this study was to determine if bacterial testing of SDPs reduced the rate of SPTRs in our hospital. STUDY DESIGN AND METHODS: An automated microbial detection system was implemented by our blood supplier in February 2004. A retrospective examination of the number of SPTRs that have occurred to SDPs at our hospital since that time was performed, using the same criteria used before bacterial screening. Transfusions over a 3.5-year period were examined. Clinical and laboratory data were gathered and correlated from transfusion reaction files and three independent computer systems.
RESULTS: From March 1, 2004, through August 31, 2007, there were 49,625 transfusions of SDPs with 1096 transfusion reactions reported. Only one reaction detected the same organism in two of three sites, meeting our criteria for a SPTR. The rate of SPTRs in SDPs was identified as 1 in 49,625 (2.0 per 100,000; 95% CI, 0.05-11.2 per 100,000). This represents a 69.7% reduction in the incidence of SPTRs (p = 0.41).
CONCLUSION: With the implementation of bacterial testing, a decrease in the rate of SPTRs to SDPs from 6.6 per 100,000 to 2.0 per 100,000 transfusions was observed. Although not significant, these findings suggest a trend.

Entities:  

Mesh:

Year:  2009        PMID: 19694995      PMCID: PMC3127255          DOI: 10.1111/j.1537-2995.2009.02348.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

Review 1.  Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.

Authors:  Christopher D Hillyer; Cassandra D Josephson; Morris A Blajchman; Jaroslav G Vostal; Jay S Epstein; Jesse L Goodman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2003

2.  Bacterial contamination of blood: lessons from the past and road map for the future.

Authors:  Roslyn Yomtovian
Journal:  Transfusion       Date:  2004-03       Impact factor: 3.157

Review 3.  Bacterial contamination of blood components.

Authors:  Mark E Brecher; Shauna N Hay
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004.

Authors:  Chyang T Fang; Linda A Chambers; Jean Kennedy; Annie Strupp; Mei-Chien H Fucci; Jo Ann Janas; Yanlin Tang; Cheryl A Hapip; Teri B Lawrence; Roger Y Dodd
Journal:  Transfusion       Date:  2005-12       Impact factor: 3.157

5.  Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets.

Authors:  Steven H Kleinman; Hany T Kamel; Dennis R Harpool; Sandra K Vanderpool; Brian Custer; Thomas B Wiltbank; Kim-Anh Nguyen; Peter A Tomasulo
Journal:  Transfusion       Date:  2006-10       Impact factor: 3.157

6.  A model to predict the improvement of automated blood culture bacterial detection by doubling platelet sample volume.

Authors:  Stephen J Wagner; Anne F Eder
Journal:  Transfusion       Date:  2007-03       Impact factor: 3.157

7.  Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).

Authors:  Anne F Eder; Jean M Kennedy; Beth A Dy; Edward P Notari; John W Weiss; Chyang T Fang; Stephen Wagner; Roger Y Dodd; Richard J Benjamin
Journal:  Transfusion       Date:  2007-07       Impact factor: 3.157

8.  Single-donor platelets reduce the risk of septic platelet transfusion reactions.

Authors:  P Ness; H Braine; K King; C Barrasso; T Kickler; A Fuller; N Blades
Journal:  Transfusion       Date:  2001-07       Impact factor: 3.157

9.  Transfusion-transmitted bacterial infection in the United States, 1998 through 2000.

Authors:  M J Kuehnert; V R Roth; N R Haley; K R Gregory; K V Elder; G B Schreiber; M J Arduino; S C Holt; L A Carson; S N Banerjee; W R Jarvis
Journal:  Transfusion       Date:  2001-12       Impact factor: 3.157

  9 in total
  9 in total

1.  Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.

Authors:  Matthew Kelly; Margaret Conway; Kathleen Wirth; Gail Potter-Bynoe; Amy L Billett; Thomas J Sandora
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09-20       Impact factor: 3.254

Review 2.  Septic shock during platelet transfusion in a patient with acute myeloid leukaemia.

Authors:  Julie Haesebaert; Thomas Bénet; Mauricette Michallet; Philippe Vanhems
Journal:  BMJ Case Rep       Date:  2013-10-30

Review 3.  Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2010-04

4.  Pathogen reduction of double-dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects.

Authors:  Konrad Rosskopf; Wolfgang Helmberg; Peter Schlenke
Journal:  Transfusion       Date:  2020-07-03       Impact factor: 3.157

5.  Investigating Transfusion-related Sepsis Using Culture-Independent Metagenomic Sequencing.

Authors:  Emily Crawford; Jack Kamm; Steve Miller; Lucy M Li; Saharai Caldera; Amy Lyden; Deborah Yokoe; Amy Nichols; Nam K Tran; Sarah E Barnard; Peter M Conner; Ashok Nambiar; Matt S Zinter; Morvarid Moayeri; Paula Hayakawa Serpa; Brian C Prince; Jenai Quan; Rene Sit; Michelle Tan; Maira Phelps; Joseph L Derisi; Cristina M Tato; Charles Langelier
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

6.  The pursuit of platelet safety.

Authors:  Paul M Ness
Journal:  Transfusion       Date:  2022-05-04       Impact factor: 3.337

7.  Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial.

Authors:  Duan Wang; Hui Zhu; Wei-Kun Meng; Hao-Yang Wang; Ze-Yu Luo; Fu-Xing Pei; Qi Li; Zong-Ke Zhou
Journal:  BMC Musculoskelet Disord       Date:  2018-03-15       Impact factor: 2.362

8.  Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration.

Authors:  Duan Wang; Hao-Yang Wang; Chang Cao; Ling-Li Li; Wei-Kun Meng; Fu-Xing Pei; De-Hua Li; Zong-Ke Zhou; Wei-Nan Zeng
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

9.  The optimal regimen of oral tranexamic acid administration for primary total knee/hip replacement: a meta-analysis and narrative review of a randomized controlled trial.

Authors:  Wei Ye; Yafang Liu; Wei Feng Liu; Xiao Long Li; Jianshu Shao
Journal:  J Orthop Surg Res       Date:  2020-10-06       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.